Product Liability

GLP-1 Receptor Agonists (Ozempic, Wegovy) Gastroparesis Litigation

GLP-1 Receptor Agonists (Ozempic, Wegovy) Gastroparesis Litigation — Product Liability class action lawsuit

Case Overview

This emerging multidistrict litigation (MDL) involves claims from users of GLP-1 receptor agonist drugs, such as Ozempic, Wegovy, and Mounjaro, who allege they developed a severe medical condition known as gastroparesis, or "stomach paralysis." These drugs, wildly popular for diabetes management and weight loss, work by slowing down digestion, which helps control blood sugar and creates a feeling of fullness.

However, plaintiffs in the lawsuit claim that for some individuals, this effect is far more extreme and persistent, leading to a chronic condition where the stomach cannot empty itself properly. Symptoms include severe nausea, vomiting, abdominal pain, and malnutrition. The lawsuits allege that the drug manufacturers, Novo Nordisk and Eli Lilly, failed to adequately warn patients and the medical community about the risk of developing severe or long-lasting gastroparesis.

Frequently Asked Questions

Can I sue Novo Nordisk or Eli Lilly for gastroparesis caused by Ozempic or Wegovy?

Yes, if you developed gastroparesis after using Ozempic, Wegovy, or other GLP-1 receptor agonists, you may have grounds for a product liability lawsuit against the manufacturers. You can join the class action litigation if you meet the eligibility requirements, which typically include having a gastroparesis diagnosis following use of these medications.

How do I get money from a GLP-1 gastroparesis settlement?

If you're a class member and a settlement is reached, you can file a claim with the settlement administrator. You'll typically need to submit proof of your Ozempic or Wegovy use and gastroparesis diagnosis. Once approved, you'll receive your settlement award from the fund established by the defendants.

What symptoms of gastroparesis qualify for the GLP-1 drug lawsuit?

Gastroparesis symptoms that may qualify include severe stomach paralysis, nausea, vomiting, bloating, and difficulty digesting food after taking Ozempic, Wegovy, or similar GLP-1 drugs. Medical records documenting your diagnosis and its timing in relation to medication use are important for your claim.

Related Cases

Toyota Hybrid Inverter Defect Lawsuit — Product Liability class action lawsuit

Toyota Hybrid Inverter Defect Lawsuit

Current
Product Liability
A class action lawsuit has been filed against Toyota concerning alleged dangerous defects in the hybrid inverter components of certain Corolla and Camry models. The plaintiff claims Toyota knowingly sold these vehicles with a defect before issuing a recall.
Honda Keyless Entry System Theft Vulnerability Lawsuit — Product Liability class action lawsuit

Honda Keyless Entry System Theft Vulnerability Lawsuit

Current
Product Liability
A class action lawsuit has been filed alleging that Honda vehicles equipped with passive keyless entry systems are susceptible to theft due to undisclosed vulnerabilities. The plaintiff claims the company engaged in deceptive trade practices by failing to disclose these security flaws to consumers.
GM Class Action Lawsuit Over Defective Brake Cylinder Assemblies — Product Liability class action lawsuit

GM Class Action Lawsuit Over Defective Brake Cylinder Assemblies

Current
Product Liability
General Motors is facing a class action lawsuit concerning vehicles that allegedly had defective master brake cylinder assemblies. The suit specifically names certain model years of Chevrolet, GMC, Buick, and Colorado vehicles.